Martin O. Leach

Curation of myeloma observational study MALIMAR using XNAT: solving the challenges posed by real-world data

Simon Doran, Theo Barfoot, Linda Wedlake, Jessica Winfield et autres

gb, es (code pays fourni par la source)

Characterisation of paediatric brain tumours by their MRS metabolite profiles

Simrandip K. Gill, Heather Rose, Martin Wilson, Daniel Rodriguez Gutierrez et autres

gb, in, ca (code pays fourni par la source)

Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial

Lucas Moreno, Rebekah Weston, Cormac Owens, Dominique Valteau‐Couanet et autres

es, gb, ie, fr, nl, dk, ch, it, be, at (code pays fourni par la source)

Supplementary Materials and Methods and Supplementary Figures 1-6 from The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate–Lactate Exchange in BRAF-Mutant Human Melanoma Cells

Teresa Delgado‐Goñi, Maria Falck Miniotis, Slawomir Wantuch, Harold G. Parkes et autres

Supplementary Materials and Methods and Supplementary Figures 1-6 from The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate–Lactate Exchange in BRAF-Mutant Human Melanoma Cells

Teresa Delgado‐Goñi, Maria Falck Miniotis, Slawomir Wantuch, Harold G. Parkes et autres

Data from The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate–Lactate Exchange in BRAF-Mutant Human Melanoma Cells

Teresa Delgado‐Goñi, Maria Falck Miniotis, Slawomir Wantuch, Harold G. Parkes et autres

Data from The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate–Lactate Exchange in BRAF-Mutant Human Melanoma Cells

Teresa Delgado‐Goñi, Maria Falck Miniotis, Slawomir Wantuch, Harold G. Parkes et autres

Data from Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined

Eveline A.M. Heijnsdijk, Ellen Warner, Fiona J. Gilbert, Madeleine M.A. Tilanus‐Linthorst et autres

Supplementary Materials, Methods and Figures from MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy

Mounia Beloueche‐Babari, Slawomir Wantuch, Markela Koniordou, Harold G. Parkes et autres

Supplementary Materials, Methods and Figures from MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy

Mounia Beloueche‐Babari, Slawomir Wantuch, Markela Koniordou, Harold G. Parkes et autres

Data from MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy

Mounia Beloueche‐Babari, Slawomir Wantuch, Markela Koniordou, Harold G. Parkes et autres

Data from MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy

Mounia Beloueche‐Babari, Slawomir Wantuch, Markela Koniordou, Harold G. Parkes et autres